Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View | |
Shi Hu; Shuaiyi Liang; Huaizu Guo; Dapeng Zhang; Hui Li; Xiaoze Wang; Weili Yang; Weizhu Qian; Sheng Hou; Hao Wang | |
刊名 | Journal of Biological Chemistry
![]() |
2013 | |
卷号 | Vol.288 No.38页码:27059-27067 |
关键词 | Antibodies Autoimmune Diseases Crystal Structure Protein Targeting Tumor Necrosis Factor (TNF) Adalimumab Epitope Mechanism |
ISSN号 | 0021-9258 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/1861937 |
专题 | 南开大学 |
作者单位 | From the ‡Laboratory of Structural Biology and Ministry of Education Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing 100084, China, the §International Joint Cancer Institute, Second Military Medical University, Shanghai 200433, China, the ¶National Engineering Research Center for Antibody Medicine and Shanghai Key Laboratory of Cell Engineering & Antibody, Shanghai 201203, China, the ‖People's Liberation Army General Hospital Cancer Center, PLA Postgraduate School of Medicine, Beijing 100853, China, and the **School of Medicine, Nankai University, Tianjin 300071, China |
推荐引用方式 GB/T 7714 | Shi Hu,Shuaiyi Liang,Huaizu Guo,et al. Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View[J]. Journal of Biological Chemistry,2013,Vol.288 No.38:27059-27067. |
APA | Shi Hu.,Shuaiyi Liang.,Huaizu Guo.,Dapeng Zhang.,Hui Li.,...&Zhiyong Lou.(2013).Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View.Journal of Biological Chemistry,Vol.288 No.38,27059-27067. |
MLA | Shi Hu,et al."Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View".Journal of Biological Chemistry Vol.288 No.38(2013):27059-27067. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论